Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer.

ESMO open·2025
Same author

MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy.

ESMO open·2022
Same author

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).

Radiation oncology (London, England)·2022
Same author

Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2.

International journal of stroke : official journal of the International Stroke Society·2019
Same author

[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Zeitschrift fur Rheumatologie·2018
Same author

[Big data from clinical routine].

Zeitschrift fur Rheumatologie·2018
Same journal

Full robotic endovascular treatment for various head and neck hemorrhagic lesions.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
Same journal

Publisher's note.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
Same journal

Expression of Concern.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
Same journal

Erratum to "Initial experience with the antithrombogenic-coated CARESTOstent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter study".

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
Same journal

Transcirculation retrograde deployment of Neuroform Atlas stent-assisted coil embolization for a superior cerebellar artery aneurysm.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
Same journal

Retrieval of a fractured radial access catheter from the axillary artery.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Making evidence available: prognostic classification systems.

U Mansmann1

  • 1Institute of Medical Statistics, Free University; Berlin, Germany.

Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences
|August 4, 2010
PubMed
Summary
This summary is machine-generated.

Accurate prognostic systems are crucial for managing treatment risks when data is ambiguous. Standardizing prognostic factor analysis ensures reliable patient risk identification and clear communication of clinical experience.

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Medical Informatics
  • Clinical Epidemiology
  • Biostatistics

Background:

  • Treatment selectivity claims often lack independent data validation.
  • Ambiguous therapy risk information creates management challenges.
  • Identifying patients at risk requires clear prognostic criteria.

Purpose of the Study:

  • To highlight the importance of accurate prognostic assessment in clinical decision-making.
  • To address the challenges posed by unvalidated treatment selectivity claims.
  • To emphasize the need for standardization in prognostic factor analysis.

Main Methods:

  • Review of existing literature on treatment selectivity and prognostic factor analysis.
  • Discussion of the implications of non-standardized prognostic studies.
  • Conceptual development of a standardized prognostic system.

Main Results:

  • Most claims of treatment selectivity lack independent supporting data.
  • Lack of standardization hinders comparability between prognostic studies.
  • Prognostic factor analysis requires rigorous standardization for reliable results.

Conclusions:

  • Accurate prognostic systems are essential for navigating therapeutic uncertainties.
  • Standardization in prognostic factor analysis is critical for reliable patient risk stratification.
  • A well-defined prognostic system facilitates unambiguous communication of clinical expertise.